+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 1Month - 59Months
All Genders
Healthy Volunteers
ID06358872

Azithromycin Mass Drug Distribution for Child Survival and Monitoring of Antimicrobial Resistance in Niger

Led by University of California, San Francisco · Updated on 2026-08-17

3300000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the impact of azithromycin mass drug administration MDA on child survival and antimicrobial resistance AMR in Niger. This adaptive platform trial focuses on monitoring under-5 mortality rates and AMR as the azithromycin program expands nationwide. The study aims to track mortality trends over time relative to global reduction targets and to assess the ongoing effectiveness and risks associated with azithromycin use in children. Participants receive azithromycin distribution targeted to children aged 1 to 59 months, delivered door-to-door by community health workers. The study compares three groups continuous azithromycin distribution for four years, delayed distribution beginning after two years, and stopping distribution after two years. This design includes monitoring and re-randomization every two years to adapt the intervention based on observed outcomes. During the study, participants undergo surveillance for mortality and AMR through nasopharyngeal and rectal swabs collected at two- and four-year intervals. Researchers measure all-cause mortality, prevalence of macrolide resistance, genetic resistance markers, and frequency of infectious clinic visits. The trial includes verbal approvals from communities and caregivers, and tracks program costs and reported illnesses over time, with a total duration extending to four years of treatment and monitoring.

CONDITIONS

Brief Title

Azithromycin for Child Survival in Niger II

Research Team

A

Andrea R Picariello, MPH

E

Elodie Lebas

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here